Canton Biologics

About Canton Biologics

Canton Biologics is a globally integrated CDMO, operating four core sites across China and Germany and serving over 100 biopharma clients worldwide. Our capabilities span six advanced solution areas: Innovative Drug Solutions, Biosimilar Solutions, ATMP Solutions (including oncolytic viruses, CAR-T cell therapies, LBPs, and exosome-based therapies), Biologics Solutions for Companion Animals, ...

  • Country/Region:
    Hong Kong
  • Founded:
    2016
  • On CPHI since:
    2026
  • Employees:
    250 - 499
Company types
CMO/CDMO
Contact info
  • UNIT 511 OF 5/F OF BUILDING 5W,, PHASE ONE, HONG KONG SCIENCE PARK, 000000, Hong Kong, Hong Kong

Products from Canton Biologics (3)

  • Biologics Development Solutions for Companion Animal Therapeutics

    Product Biologics Development Solutions for Companion Animal Therapeutics

    Leverages advanced expression technologies, optimised vectors, and flexible bioprocessing platforms to deliver scalable and cost‑efficient solutions tailored to companion animal biologics. Supports from early development to GMP manufacturing, with customisation for veterinary specific requirements.

  • Biomedical and Healthcare Recombinant Protein Solutions

    Product Biomedical and Healthcare Recombinant Protein Solutions

    Combines molecular engineering, host cell optimisation, expression system development, and process optimisation to address complex protein structures. The IgMax® platform enables production of pentameric IgM at high expression levels, with near‑complete pentamer assembly and excellent purity after downstre...
  • Innovative Drug Solutions for Difficult‑to‑Express and Complex Proteins

    Product Innovative Drug Solutions for Difficult‑to‑Express and Complex Proteins

    Integrated development and manufacturing solutions combining molecular engineering, vector optimization, host cell engineering, and customized process development. The platform delivers high titers for mAb production, and DTEasy™ strategies have demonstrated significant yield improvements across various di...